List of works - Ivar Skaland

A protein profile study to discriminate CIN lesions from normal cervical epithelium.

scientific article

Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression

scientific article

Androgen receptor determination in breast cancer: a comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis

scientific article published on 01 July 2008

Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer

scientific article published on 11 March 2008

Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis

scientific article published on 01 December 2018

Biologic profiling of lymph node negative breast cancers by means of microRNA expression ⬇️

scientific article published on September 3, 2010

Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma ⬇️

scientific article published on May 6, 2011

Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?

scientific article

Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.

scientific article published in January 2007

Cervical intraepithelial neoplasia grade 3 lesions can regress

scientific article published on December 2007

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

scientific article

Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions

scientific article published in August 2005

Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.

scientific article

Comparison of apolipoprotein D determination methods in breast cancer

scientific article published on 01 March 2008

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer ⬇️

scientific article published on September 11, 2012

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study ⬇️

scientific article published on November 5, 2012

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients ⬇️

scientific article published on February 11, 2011

Digital image analysis improves the quality of subjective HER-2 expression scoring in breast cancer

scientific article

Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies ⬇️

scientific article published on June 28, 2011

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers

scientific article published on 5 May 2006

Evaluation of 5 different labeled polymer immunohistochemical detection systems

scientific article

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics

scientific article published on 7 February 2018

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

scientific article published on 08 November 2019

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression

scientific article

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

scientific article

Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression

scientific article published on 01 May 2005

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.

scientific article

Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ

scientific article published on 30 January 2008

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

scientific article published on 04 December 2019

Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.

scientific article

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers

scientific article published on 05 May 2020

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer

scientific article published on 02 June 2020

Molecular biomarkers in endometrial hyperplasias predict cancer progression ⬇️

scientific article published on February 16, 2011

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

scientific article

Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer

scientific article published on 20 April 2020

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder

scientific article published on 26 March 2014

Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer

scientific article published on April 1, 2013

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.

scientific article published on 4 March 2008

Prognostic relevance of androgen receptor detection in operable breast cancer

scientific article

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer

scientific article

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

scientific article

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

scientific article published on 01 July 2009

Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability

scientific article published on April 2004

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3 ⬇️

scientific article published on 01 April 2011

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer ⬇️

scientific article published on 08 July 2012

The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer

scientific article

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.

scientific article published on 30 October 2008

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer

scientific article published on February 1, 2011

The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer.

scientific article published in January 2009

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

scientific article

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers ⬇️

scientific article published on November 7, 2012

List of works by Ivar Skaland

A protein profile study to discriminate CIN lesions from normal cervical epithelium.

Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression

Androgen receptor determination in breast cancer: a comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis

Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer

Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis

Biologic profiling of lymph node negative breast cancers by means of microRNA expression ⬇️

Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma ⬇️

Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?

Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.

Cervical intraepithelial neoplasia grade 3 lesions can regress

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions

Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.

Comparison of apolipoprotein D determination methods in breast cancer

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer ⬇️

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study ⬇️

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients ⬇️

Digital image analysis improves the quality of subjective HER-2 expression scoring in breast cancer

Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies ⬇️

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers

Evaluation of 5 different labeled polymer immunohistochemical detection systems

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.

Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer

Molecular biomarkers in endometrial hyperplasias predict cancer progression ⬇️

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder

Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.

Prognostic relevance of androgen receptor detection in operable breast cancer

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3 ⬇️

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer ⬇️

The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer

The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer.

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers ⬇️

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients